Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1
利用直接重编程的人类神经元研究年龄和独特抗逆转录病毒疗法对 HIV-1 感染者的分子影响
基本信息
- 批准号:10414084
- 负责人:
- 金额:$ 21.45万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAgeAge-YearsAgingAnti-Retroviral AgentsAutophagocytosisBehavioralBiologicalBiological AssayBiopsyBlood - brain barrier anatomyCarrier ProteinsCell modelCharacteristicsClinicalCognitionCognitiveCollaborationsComplexConfounding Factors (Epidemiology)Control GroupsDataDefectDermalDevelopmentDiseaseDown-RegulationElderlyEnrollmentFibroblastsFlow CytometryFunctional disorderGene ExpressionGene Expression ProfileGene Expression ProfilingGenesGenetic TranscriptionHIVHIV SeronegativityHIV SeropositivityHIV-1HIV-associated neurocognitive disorderHealthHumanImpaired cognitionImpairmentIn VitroIncidenceIndividualInflammationInjuryIntegraseMemorial Sloan-Kettering Cancer CenterMethodsMolecularMorphologyNeuraxisNeurocognitiveNeurocognitive DeficitNeurogliaNeuronal InjuryNeuronsNeuropsychological TestsNuclear PoreOntologyOxidative StressParticipantPathway interactionsPatientsPersonsPharmaceutical PreparationsPhenotypePhysiologicalPopulationPrevalenceProtease InhibitorRattusRegimenReporterReportingSamplingSkinStem Cell ResearchSystemTechnologyTestingTissue-Specific Gene ExpressionValidationage effectage relatedantiretroviral therapybaseclinical carecohortcomorbidityhuman diseaseimmunocytochemistryimprovedinduced pluripotent stem cellinhibitorinterestmitochondrial dysfunctionneurotrophic factornovelresearch facilitysecondary analysissexstem cellstherapeutic targettooltranscriptome sequencingtranslational study
项目摘要
PROJECT SUMMARY/ABSTRACT
Despite advances in clinical care, people living with HIV-1 (PLWH) on long-term antiretroviral therapy (ART) still
present with cognitive and behavioral deficits and the prevalence of HIV-1 associated neurocognitive disorders
(HANDs) is 30%-50%. The mechanisms underlying HIV-induced central nervous system (CNS) dysfunction in
these patients are complex, multifactorial and difficult to study using current methods. In this proposal, we will
investigate modifiable mechanistic pathways of neuronal aging in HIV-1 using physiologically relevant,
participant-derived cell models. In recent years, the ability to generate directly induced neurons (iNs) from
patient-derived fibroblasts has been demonstrated. Unlike the immature neuronal populations generated from
induced pluripotent stem cells (iPSCs), iNs retain neuron-specific, aging-associated gene-expression
characteristics of the donor. As a result, these iNs represent a major technological advance. Our preliminary
data demonstrates our ability to generate iNs from the skin biopsies of PLWH. To our knowledge, this makes us
the first group to apply this technology to study of neuronal health in HIV-1. We now propose to use these tools
to determine if differences in gene expression reflective of accelerated age- and/or additional HIV disease-
associated transcriptional signatures are evident through the transcriptional phenotyping of iNs derived from
age-matched young and older HIV-negative and HIV-positive cohorts. Functional analyses of the iNs will test
hypothesized pathomechanisms of neuronal aging. A growing body of scientific evidence also suggests that
antiretroviral drugs (ARVs) widely used in HIV-1 therapy and known to cross the blood-brain barrier to varying
degrees may have class- and/or drug-specific deleterious effects on neuronal health. We therefore, in
exploratory secondary analyses, hypothesize that there are potentially modifiable, mechanistic pathways of
neuronal injury in HIV-1 that are also ARV class dependent. We will investigate our hypotheses in two specific
aims. In AIM 1, we will generate patient-derived iNs from clinically well-characterized participants. We will
generate iNs as per Mertens et al. (Cell Stem Cell, 2015) from the skin biopsies of 6 clinically well-defined cohorts
stratified by age, HIV-1 status and use of protease-inhibitor (PI)- versus Integrase strand
transfer inhibitor (INSTI)-based ART. In AIM 2, we will determine neuronal-associated gene-expression
pathways modulated by age, HIV-1 status and cART usage through transcriptional profiling of iNs from well-
defined clinical cohorts. Differential gene expression analysis will be performed across cohorts in attempts to
determine, age (old vs. young), and in secondary exploratory analyses, HIV-1 (positive vs. negative) and ARV
(PI vs. INSTI) effects on gene transcription. We will then determine if age-dependent nucleocytoplasmic
compartmentalization (NCC) impairments characterize iNs from older, HIV-1 positive cohorts. Our novel
application of this iNs technology to the translational study of PLWH allows us the opportunity to fill a gap in our
understanding of neuronal aging in HIV-1 and identify therapeutic targets for improved cognition.
项目摘要/摘要
尽管临床护理取得了进步,但长期抗逆转录病毒疗法(ART)患有HIV-1(PLWH)的人仍在
存在认知和行为缺陷以及HIV-1相关神经认知疾病的流行率
(手)为30%-50%。 HIV引起的中枢神经系统(CNS)功能障碍的机制
这些患者是复杂的,多因素的,并且难以使用当前方法研究。在此提案中,我们将
使用生理上的相关,研究HIV-1中神经元衰老的可修改机械途径,
参与者衍生的细胞模型。近年来,从
已经证明了患者来源的成纤维细胞。与未成熟的神经元种群不同
诱导多能干细胞(IPSC),INS保留神经元特异性,与衰老相关的基因表达
捐赠者的特征。结果,这些INS代表了主要的技术进步。我们的初步
数据证明了我们从PLWH的皮肤活检中产生INS的能力。据我们所知,这使我们
第一个将该技术应用于HIV-1中神经元健康的小组。我们现在建议使用这些工具
确定基因表达的差异是否反映了加速的年龄和/或其他HIV疾病 -
通过源自源自的INS的转录表型可以明显看出相关的转录特征
年龄匹配的年龄较大和年龄较大的HIV阴性和HIV阳性队列。 INS的功能分析将测试
神经元衰老的假设病理机理。越来越多的科学证据也表明
抗逆转录病毒药物(ARV)广泛用于HIV-1治疗,已知越过血脑屏障
学位可能对神经元健康具有类和/或药物特异性的有害影响。因此,我们在
探索性二级分析,假设存在可能修改的机械途径
HIV-1的神经元损伤也依赖于ARV类。我们将以两个特定的方式研究我们的假设
目标。在AIM 1中,我们将从临床表征良好的参与者中产生患者来源的INS。我们将
根据Mertens等人的生成INS。 (细胞干细胞,2015年),来自6个临床定义良好的队列的皮肤活检
按年龄,HIV-1状态和使用蛋白酶抑制剂(PI)与整合酶链分层
基于转移抑制剂(Insti)的艺术。在AIM 2中,我们将确定与神经元相关的基因表达
通过年龄,HIV-1状态和手推车使用的途径通过从良好的转录进行转录分析
定义的临床队列。差异基因表达分析将在跨人群中进行
确定,年龄(旧与年轻),以及在次要探索性分析中,HIV-1(正面与负)和ARV
(PI与Insti)对基因转录的影响。然后,我们将确定年龄依赖性的核细胞质
隔室化(NCC)的损害表征了来自较老的HIV-1阳性队列的INS。我们的小说
将此INS技术应用于PLWH的翻译研究,使我们有机会填补我们的空白
了解HIV-1中神经元衰老并确定改善认知的治疗靶标。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The comorbidity of depression and neurocognitive disorder in persons with HIV infection: call for investigation and treatment.
- DOI:10.3389/fncel.2023.1130938
- 发表时间:2023
- 期刊:
- 影响因子:5.3
- 作者:
- 通讯作者:
Cellular rejuvenation to combat HIV-1-related neurocognitive impairment.
细胞再生对抗 HIV-1 相关的神经认知障碍。
- DOI:10.1016/j.tim.2023.09.011
- 发表时间:2024
- 期刊:
- 影响因子:15.9
- 作者:Ostermann,PhilippN;Evering,TeresaH
- 通讯作者:Evering,TeresaH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Teresa Evering其他文献
Teresa Evering的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Teresa Evering', 18)}}的其他基金
A Precision Medicine Approach to Investigating the Molecular Impact of Age and Neurocognitive Impairment in People Living with HIV (PLWH)
采用精准医学方法研究年龄和神经认知障碍对艾滋病毒感染者 (PLWH) 的分子影响
- 批准号:
10403203 - 财政年份:2021
- 资助金额:
$ 21.45万 - 项目类别:
Leveraging Directly Reprogrammed Human Neurons to Investigate the Molecular Impact of Age and Distinct Antiretroviral Therapies in Individuals Living with HIV-1
利用直接重编程的人类神经元研究年龄和独特抗逆转录病毒疗法对 HIV-1 感染者的分子影响
- 批准号:
10257736 - 财政年份:2021
- 资助金额:
$ 21.45万 - 项目类别:
The Role of HIV-1 Evolution in Neuroadaptation
HIV-1 进化在神经适应中的作用
- 批准号:
8446449 - 财政年份:2010
- 资助金额:
$ 21.45万 - 项目类别:
The Role of HIV-1 Evolution in Neuroadaptation
HIV-1 进化在神经适应中的作用
- 批准号:
8640972 - 财政年份:2010
- 资助金额:
$ 21.45万 - 项目类别:
The Role of HIV-1 Evolution in Neuroadaptation
HIV-1 进化在神经适应中的作用
- 批准号:
7930425 - 财政年份:2010
- 资助金额:
$ 21.45万 - 项目类别:
The Role of HIV-1 Evolution in Neuroadaptation
HIV-1 进化在神经适应中的作用
- 批准号:
8232111 - 财政年份:2010
- 资助金额:
$ 21.45万 - 项目类别:
The Role of HIV-1 Evolution in Neuroadaptation
HIV-1 进化在神经适应中的作用
- 批准号:
8076235 - 财政年份:2010
- 资助金额:
$ 21.45万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Sensitive periods for prenatal alcohol exposure: a longitudinal study of DNA methylation and subsequent mental health
产前酒精暴露的敏感期:DNA 甲基化和随后心理健康的纵向研究
- 批准号:
10573715 - 财政年份:2023
- 资助金额:
$ 21.45万 - 项目类别:
Measuring the Impact of the Value Flower and Unobserved Heterogeneity on the Cost Effectiveness and Use of Novel Treatments for Alzheimer's Disease and Related Dementias
衡量价值花和未观察到的异质性对阿尔茨海默病和相关痴呆症新疗法的成本效益和使用的影响
- 批准号:
10658457 - 财政年份:2023
- 资助金额:
$ 21.45万 - 项目类别:
Theophylline Prophylaxis during Hypothermia to Limit Neonatal Nephron Damage
低温期间预防茶碱以限制新生儿肾单位损伤
- 批准号:
10656030 - 财政年份:2023
- 资助金额:
$ 21.45万 - 项目类别:
Deciphering molecular mechanisms controlling age-associated uterine adaptabilityto pregnancy
破译控制与年龄相关的子宫妊娠适应性的分子机制
- 批准号:
10636576 - 财政年份:2023
- 资助金额:
$ 21.45万 - 项目类别:
Enhancing TET activity for the treatment of hematological malignancy
增强 TET 活性治疗血液恶性肿瘤
- 批准号:
10717715 - 财政年份:2023
- 资助金额:
$ 21.45万 - 项目类别: